These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 23553288)
1. Topical tacrolimus for the management of acute allergic conjunctivitis in a mouse model. Barequet IS; Platner E; Sade K; Etkin S; Ziv H; Rosner M; Habot-Wilner Z Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1717-21. PubMed ID: 23553288 [TBL] [Abstract][Full Text] [Related]
2. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice. Shoji J; Sakimoto T; Muromoto K; Inada N; Sawa M; Ra C Jpn J Ophthalmol; 2005; 49(3):205-10. PubMed ID: 15944824 [TBL] [Abstract][Full Text] [Related]
3. Topical Application of Interleukin-28A Attenuates Allergic Conjunctivitis in an Ovalbumin-Induced Mouse Model. Chen J; Zhang J; Zhao R; Jin J; Yu Y; Li W; Wang W; Zhou H; Su SB Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):604-10. PubMed ID: 26886894 [TBL] [Abstract][Full Text] [Related]
4. Topical Administration of β-1,3-Glucan to Modulate Allergic Conjunctivitis in a Murine Model. Lee HS; Kwon JY; Joo CK Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1352-60. PubMed ID: 27002295 [TBL] [Abstract][Full Text] [Related]
5. A Biodegradable, Sustained-Released, Tacrolimus Microfilm Drug Delivery System for the Management of Allergic Conjunctivitis in a Mouse Model. Liu YC; Ng XW; Teo EPW; Ang HP; Lwin NC; Chan NSW; Venkatraman SS; Wong TT; Mehta JS Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):675-684. PubMed ID: 29392313 [TBL] [Abstract][Full Text] [Related]
6. The effect of topical FK506 (tacrolimus) in a mouse model of allergic rhinitis. Shin JH; Park HR; Kim SW; Park CS; Cho JH; Park YJ; Kim SW Am J Rhinol Allergy; 2012; 26(2):e71-5. PubMed ID: 22487280 [TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of annexin A1 in a model of experimental allergic conjunctivitis. Gimenes AD; Andrade TR; Mello CB; Ramos L; Gil CD; Oliani SM Exp Eye Res; 2015 May; 134():24-32. PubMed ID: 25795053 [TBL] [Abstract][Full Text] [Related]
8. Galectin-3: role in ocular allergy and potential as a predictive biomarker. Andrade FEC; Corrêa MP; Gimenes AD; Dos Santos MS; Campos M; Chammas R; Gomes JÁP; Gil CD Br J Ophthalmol; 2018 Jul; 102(7):1003-1010. PubMed ID: 29502069 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of allergic conjunctival granuloma by topical tacrolimus: A clinicopathologic case report. Foroutan A; Ghafourian A; Habibi A; Foroutan P; Ashrafkhorasani M; Alemzadeh SA Indian J Ophthalmol; 2018 Apr; 66(4):578-580. PubMed ID: 29582827 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of FK506 on the development of experimental allergic/immune-mediated blepharoconjunctivitis in Lewis rats by systemic but not by topical administration. Iwamoto H; Yoshida H; Yoshida O; Fukushima A; Ueno H Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):407-14. PubMed ID: 10333108 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice. Shii D; Oda T; Shinomiya K; Katsuta O; Nakamura M J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707 [TBL] [Abstract][Full Text] [Related]